chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Haematoma, Myalgia, Pain in extremity
Clinical narrative: hematoma; Pain in arm; Pain has increased since then in my upper arm muscle; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL 9263) via an unspecified route of administration in the arm left on 06Feb2021 at 15:30 (at the age of 70-year-old) as a single dose for COVID-19 immunisation. Medical history included thyroidectomy, hormone replacement therapy, sulfonamide allergy, seafood allergy (scallops) and fruit allergy (strawberries). The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included levothyroxine sodium (SYNTHROID) from an unknown date and unknown if ongoing for an unknown indication. The patient was allergic to amoxicillin and epinephrine. On 06Feb2021, the patient experienced pain in the arm and pain has increased since then in my upper arm muscle which would make it worse while exercising. On 10Feb2021, 4 days after the vaccination, the patient developed a hematoma. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain in the arm, hematoma and upper arm muscle pain were not recovered at the time of the report.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Defaecation disorder, Nausea, Vertigo, Vomiting
Clinical narrative: Intense vertigo, followed by nausea, and vomiting and defecation. This happened three times upon awakening.; Intense vertigo, followed by nausea, and vomiting and defecation. This happened three times upon awakening.; Intense vertigo, followed by nausea, and vomiting and defecation. This happened three times upon awakening.; Intense vertigo, followed by nausea, and vomiting and defecation. This happened three times upon awakening.; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 15:30 (age at vaccination unknown) as a single dose for COVID-19 immunisation. The patient previously had penicillin and experienced penicillin allergy. The patient did not receive any medication within two weeks prior to vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6207) via an unspecified route of administration in the left arm on 15Mar2021 at 15:30 (age at vaccination unknown) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient experienced intense vertigo, followed by nausea, and vomiting and defecation. This had happened three times upon awakening. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of intense vertigo, followed by nausea, and vomiting and defecation and included rest, and being stationary. The clinical outcome of the events intense vertigo, followed by nausea, and vomiting and defecation was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia, Sleep disorder, Vaccination site pain
Clinical narrative: Pain at injection site that woke me up from sleep; Pain at injection site that woke me upfrom sleep; Mild headaches; Mild low fever; Fatigue; This is a spontaneous report from a contactable consumer (patient). A 25-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in the left arm on 08Apr2021 at 19:15 (Lot Number: EW0158), at the age of 25-years-old, as a single dose for COVID-19 immunisation. Patient was not pregnant at the time of vaccination. The patient did not have any relevant medical history (none). The patient had no known allergies with food, medication or other product. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021 at 04:30, the patient experienced pain at injection site that woke up her from sleep (sleep disturbed), mild headaches, mild low fever and fatigue. No therapeutic measures were taken as a result of the reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the events pain at injection site that woke up from sleep (sleep disturbed), mild headaches, mild low fever and fatigue were recovering, at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chest pain, Dyspnoea, Polymerase chain reaction, Rash
Clinical narrative: Difficulty breathing; Chest pains; Severe joint pain in my thumbs, shoulders, knees and ankles; painful, itchy full body rash, starting on my feet and lower legs, which then spread upward.; Rash has worsened; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 16:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included history of asthma and fish allergy. Concomitant medications included vitamin d nos (VITAMIN D), ascorbic acid (VITAMIN C) and zinc (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03Mar2021 at 17:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 02Apr2021 at 18:00, approximately one week after the second dose, severe joint pain in my thumbs, shoulders, knees and ankles. After the onset of joint pain, the patient also experienced painful itchy full body rash, starting on feet and lower legs, which then spread upward. On 07Apr2021 the patient experienced difficulty breathing and chest pains and went to the emergency room (ER). The breathing issue had subsided but the rash had worsened and the joint pain had remained over the last week. Therapeutic measures were taken as a result of adverse events which included treatment with prednisone (MANUFACTURER UNKNOWN) and antihistamines. The events difficulty breathing and chest pains resulted in emergency room/department or urgent care. On 07Apr2021, the patient underwent lab test which included PCR and Rapid (Nasal swab) and the results were negative. The clinical outcome of the events rash has worsened, severe joint pain in my thumbs, shoulders, knees and ankles, painful itchy full body rash, starting on feet and lower legs, which then spread upward, difficulty breathing and chest pains were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Rash pruritic, SARS-CoV-2 test
Clinical narrative: Difficulty breathing; Chest pains; Severe joint pain in my thumbs, shoulders, knees and ankles; painful, itchy full body rash, starting on my feet and lower legs, which then spread upward.; Rash has worsened; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 16:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included history of asthma and fish allergy. Concomitant medications included vitamin d nos (VITAMIN D), ascorbic acid (VITAMIN C) and zinc (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03Mar2021 at 17:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 02Apr2021 at 18:00, approximately one week after the second dose, severe joint pain in my thumbs, shoulders, knees and ankles. After the onset of joint pain, the patient also experienced painful itchy full body rash, starting on feet and lower legs, which then spread upward. On 07Apr2021 the patient experienced difficulty breathing and chest pains and went to the emergency room (ER). The breathing issue had subsided but the rash had worsened and the joint pain had remained over the last week. Therapeutic measures were taken as a result of adverse events which included treatment with prednisone (MANUFACTURER UNKNOWN) and antihistamines. The events difficulty breathing and chest pains resulted in emergency room/department or urgent care. On 07Apr2021, the patient underwent lab test which included PCR and Rapid (Nasal swab) and the results were negative. The clinical outcome of the events rash has worsened, severe joint pain in my thumbs, shoulders, knees and ankles, painful itchy full body rash, starting on feet and lower legs, which then spread upward, difficulty breathing and chest pains were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: menstrual cycle started about 2-3 days early; This is a spontaneous report from a non-contactable consumer (patient). A 39-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 09Apr2021 at 14:45 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Patient was not pregnant at the time of vaccination. Patient had no relevant medical history (none). The patient had not reported any other health issues. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medications. The patient previously received first dose of BNT162B2 (Lot Number: unknown) via an unspecified route of administration on unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 09Apr2021 at 20:00, the patient had her menstrual cycle started about 2 to 3 days early. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of event (menstrual cycle started about 2-3 days early) was recovered on unknown date in Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chest X-ray, Lymph node pain, Lymphadenopathy, SARS-CoV-2 test
Clinical narrative: Enlarged supraclavicular lymph node 5 days after receiving the vaccine, very painful and growing each day; Enlarged supraclavicular lymph node 5 days after receiving the vaccine, very painful and growing each day; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 02Apr2021 at 10:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included cystitis interstitial, insomnia and known allergies to strawberries. Concomitant medications included trazodone (MANUFACTURER UNKNOWN), montelukast sodium (MONTELUKAST) and daily multivitamin (MANUFACTURER UNKNOWN), all from an unknown date for an unknown indication. On an unknown date, the patient received rifampin (MANUFACTURER UNKNOWN) and bactrim (MANUFACTURER UNKNOWN) and experienced allergies for both. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 08Apr2021 at 16:30, 5 days after the vaccine, the patient experienced enlarged supraclavicular lymph node, very painful and growing each day. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events which included treatment with possible antibiotics, chest X-ray and blood work on an unknown date in Apr2021. On an unknown date in Apr2021, post vaccination, the patient underwent COVID-19 test and the result was negative. The clinical outcome of enlarged supraclavicular lymph node which was very painful and growing each day was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Heart rate, Oxygen saturation
Clinical narrative: Woke up with full body ache; Headache; Chills; A temp of 100.By 11:00am fever was up to 103.1, Fever went down around10pm, and was at 100.2 at 8am the following morning, which is today.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729), via an unspecified route of administration in the right arm on 07Apr2021 at 13:00 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease. The patient did not have any allergies to medications, food, or other products. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), tiotropium bromide monohydrate (SPIRIVA) and formoterol fumarate (SYMBICORT); all from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613), via an unspecified route of administration in the right arm on 17Mar2021 at 13:00 (at the age of 43-years-old), as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 07:00, the patient woke up with full body ache, headache, chills and a temp of 100. By 11:00 fever was up to 103.1, pulse was steady at 115 beats per minute (bpm), and at one point the patient's blood o2  level was down to 91% and  fever went down around 22:00. On 09Apr2021 at 08:00, the following morning, the fever was at 100.2. At the time of reporting symptoms were improving, just a headache lingered. Therapeutic measures were not taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 08Apr2021 at 07:00, the  patient underwent lab test and procedure which included body temperature and result was shown as 100, on the same day at 11:00, the body temperature was shown as 103.1. On 08Apr2021, the  patient underwent lab test and procedure which included pulse rate, blood o2 level and results were shown as 115 bpm and 91% respectively. On 09Apr2021 at 08:00, the  patient underwent lab test and procedure which included body temperature and result was shown as 100.2. The clinical outcome of the events full body ache, headache, chills and fever were resolving at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Woke up with full body ache; Headache; Chills; A temp of 100.By 11:00am fever was up to 103.1, Fever went down around10pm, and was at 100.2 at 8am the following morning, which is today.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729), via an unspecified route of administration in the right arm on 07Apr2021 at 13:00 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease. The patient did not have any allergies to medications, food, or other products. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), tiotropium bromide monohydrate (SPIRIVA) and formoterol fumarate (SYMBICORT); all from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613), via an unspecified route of administration in the right arm on 17Mar2021 at 13:00 (at the age of 43-years-old), as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 07:00, the patient woke up with full body ache, headache, chills and a temp of 100. By 11:00 fever was up to 103.1, pulse was steady at 115 beats per minute (bpm), and at one point the patient's blood o2  level was down to 91% and  fever went down around 22:00. On 09Apr2021 at 08:00, the following morning, the fever was at 100.2. At the time of reporting symptoms were improving, just a headache lingered. Therapeutic measures were not taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 08Apr2021 at 07:00, the  patient underwent lab test and procedure which included body temperature and result was shown as 100, on the same day at 11:00, the body temperature was shown as 103.1. On 08Apr2021, the  patient underwent lab test and procedure which included pulse rate, blood o2 level and results were shown as 115 bpm and 91% respectively. On 09Apr2021 at 08:00, the  patient underwent lab test and procedure which included body temperature and result was shown as 100.2. The clinical outcome of the events full body ache, headache, chills and fever were resolving at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Dizziness, Headache, Muscle spasms
Clinical narrative: Leg cramps; Knees and back hurting; Lightheaded with headache; Knees and back hurting; Lightheaded with headache; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A non-pregnant female patient of an unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Apr2021 at 12:00, as a single dose for COVID-19 immunisation. Medical history included blood pressure high. Patient had no known allergies. Concomitant medications included diphenhydramine hydrochloride (ALLERGAN), and acetylsalicylic acid (BABY ASPIRIN) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 16:00, the patient experienced leg cramps, knees and back hurting, lightheaded with headache, nausea. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events leg cramps, knees and back hurting, lightheaded with headache, nausea was resolving.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Leg cramps; Knees and back hurting; Lightheaded with headache; Knees and back hurting; Lightheaded with headache; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A non-pregnant female patient of an unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Apr2021 at 12:00, as a single dose for COVID-19 immunisation. Medical history included blood pressure high. Patient had no known allergies. Concomitant medications included diphenhydramine hydrochloride (ALLERGAN), and acetylsalicylic acid (BABY ASPIRIN) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 16:00, the patient experienced leg cramps, knees and back hurting, lightheaded with headache, nausea. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events leg cramps, knees and back hurting, lightheaded with headache, nausea was resolving.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysgeusia, Headache, Muscle spasms, Muscle tightness
Clinical narrative: hives; swollen injection site; fever; chills; muscle tension; muscle spasms; nausea; headache; metallic taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 10:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis. Concomitant medications included venlafaxine hydrochloride (VENLAFAXINE) and omeprazole (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date, unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Mar2021 at 10:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 08Apr2021 at 23:30, 13hours post vaccination, the patient experienced hives, swollen injection site, fever, chills, muscle tension and spasms, nausea, headache and metallic taste in mouth. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of hives, swollen injection site, fever, chills, muscle tension and spasms, nausea, headache and metallic taste in mouth were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Urticaria, Vaccination site swelling
Clinical narrative: hives; swollen injection site; fever; chills; muscle tension; muscle spasms; nausea; headache; metallic taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 10:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis. Concomitant medications included venlafaxine hydrochloride (VENLAFAXINE) and omeprazole (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date, unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Mar2021 at 10:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 08Apr2021 at 23:30, 13hours post vaccination, the patient experienced hives, swollen injection site, fever, chills, muscle tension and spasms, nausea, headache and metallic taste in mouth. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of hives, swollen injection site, fever, chills, muscle tension and spasms, nausea, headache and metallic taste in mouth were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Gout, Headache, Hot flush
Clinical narrative: Swollen joints are most likely agout flare-up from the vaccine'singredients.; swollen joints; hot flashes due to fever; body aches and soreness; various degrees of fever; headache; chills; achy joints, mostly concentrated on the left side of the body - fingers, elbow, knee, ankle and foot.; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6207) via an unspecified route of administration in the left arm on 06Apr2021 at 10:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, cholesterol high, gout, body mass index high (high bmi). The patient previously received niacin (MANUFACTURER UNKNOWN) and vitamin D (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. The patient received other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6205) via an unspecified route of administration in the left arm on 16Mar2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 16:00 after the second dose of COVID-19 vaccine, the patient experienced various degrees of fever, body aches and soreness, headache, chills and hot flashes due to fever, swollen and achy joints, mostly concentrated on the left side of the body - fingers, elbow, knee, ankle and foot. Swollen joints were most likely a gout flare-up from the vaccine's ingredients. It was unknown whether therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events various degrees of fever, body aches and soreness, headache, chills and hot flashes due to fever, swollen and achy joints, swollen joints and gout flare-up were not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling, Pain, Pyrexia
Clinical narrative: Swollen joints are most likely agout flare-up from the vaccine'singredients.; swollen joints; hot flashes due to fever; body aches and soreness; various degrees of fever; headache; chills; achy joints, mostly concentrated on the left side of the body - fingers, elbow, knee, ankle and foot.; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6207) via an unspecified route of administration in the left arm on 06Apr2021 at 10:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, cholesterol high, gout, body mass index high (high bmi). The patient previously received niacin (MANUFACTURER UNKNOWN) and vitamin D (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. The patient received other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6205) via an unspecified route of administration in the left arm on 16Mar2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 16:00 after the second dose of COVID-19 vaccine, the patient experienced various degrees of fever, body aches and soreness, headache, chills and hot flashes due to fever, swollen and achy joints, mostly concentrated on the left side of the body - fingers, elbow, knee, ankle and foot. Swollen joints were most likely a gout flare-up from the vaccine's ingredients. It was unknown whether therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events various degrees of fever, body aches and soreness, headache, chills and hot flashes due to fever, swollen and achy joints, swollen joints and gout flare-up were not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Muscular weakness, Paraesthesia
Clinical narrative: I cant use my right hand, weak wrist ,fingers doesnt work, feel numbnesssometimes mostly in a hand, fewtimes felt higher in an arm, sometimesfeel numbness in my face, aroundeyes; felt right arm was coldcomparing with left, primary caredoctors impression - paresthesia afterreceiving vaccine.; I cant use my right hand, weak wrist ,fingers doesnt work,; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP 7533 (not sure)) via an unspecified route of administration in the right arm on 02Apr2021 at 09:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Patient had no allergies to food, medications or other products. Patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 03Apr2021, the patient stated that she could not use her right hand, weak wrist, fingers did not work, felt numbness sometimes mostly in a hand, few times felt higher in an arm, sometimes felt numbness in face, around eyes. Felt right arm was cold comparing with left, primary care doctor's impression paraesthesia after receiving vaccine. Patient was referred to neurologist. Patient will be seeing neurologist at the end of the month. Patient next vaccine shot was scheduled at May 1st and was very concern to take vaccine. The patient did not receive any treatment for the events. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events numbness, could not use her right hand, weak wrist, fingers did not work, felt numbness sometimes mostly in a hand, few times felt higher in an arm, sometimes felt numbness in face, around eyes and paraesthesia were not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Hypoaesthesia
Clinical narrative: Very slight feeling of numbness or pressure in a small area of my face near my mouth; Very slight feeling of numbness or pressure in a small are of my face near my mouth; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 14:15 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, fibromyalgia, migraine, environmental allergy, anxiety, asthma, hyperlipidemia, blood pressure high, pre-diabetes, neuralgia, neuropathy and anemia. The patient received other medications within two weeks of vaccination, names were unspecified. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 19Mar2021 at 14:15 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 15:00 the patient experienced very slight feeling of numbness or pressure in a small area of face near her mouth. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event very slight feeling of numbness or pressure in a small area of face near her mouth was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Throat irritation
Clinical narrative: An uncomfortable feeling in the back of throat; "Within a few hours my arm is terribly sore arm"; "by the end of the night I felt slight nausea"; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 10:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included renal failure, high blood pressure , PTSD, depression, asthma, anxiety, GERDS, kidney cancer (left kidney removed) and COVID-19. The patient had known allergies to penicillin and cephalosporins. Concomitant medications included buspirone hydrochloride (BUSPIRONE), amlodipine (MANUFACTURER UNKNOWN), norethisterone (NORLYDA), apixaban (ELIQUIS), lurasidone hydrochloride (LATUDA) and other unspecified drug; all from unknown dates for unknown indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 at 11:00, after the patient first got the shot, the patient experienced an uncomfortable feeling in the back of the throat, within a few hours her arm was terribly sore and by the end of the night she felt slight nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events an uncomfortable feeling in the back of the throat, within a few hours her arm was terribly sore and by the end of the night felt slight nausea was resolved on an unknown date in Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm after injection; This is a spontaneous report from a non-contactable consumer, the patient. A unspecified aged male patient received, an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew 0153) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unknown date the patient experienced sore arm after injection. The clinical outcome of the event sore arm after injection was unknown at the time of this report.   No follow up attempts are possible; No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Inappropriate schedule of product administration, Myalgia, Pyrexia
Clinical narrative: Fatigue; Fever; Muscle aches; Headache; Inappropriate schedule of vaccine administered; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737), via an unspecified route of administration in the left arm on 08Apr2021 at 14:15 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Medical history included kidney stones, cholecystectomy and elevated cholesterol. Concomitant medications included omega-3-acid ethyl ester (OMEGA-3 ETHYL ESTERS), ergocalciferol (VITAMIN D2) and dopamine hydrochloride (MEGADOSE); all from unknown dates for unspecified indications. The patient patient previously took dilaudid on unknown date for an unspecified indication and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613), via an unspecified route of administration in the left arm on 22Mar2021 at 16:45 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 14:15, onset at 24 hours post dose 2, the patient experienced fatigue then fever then muscle aches and then headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the reported events and included treatment with tylenol pm. The clinical outcome of the events fatigue, fever, muscle aches and headache were not recovered at the time of reporting.   No follow-up attempts are possible. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swollen lymph node near collar bone; This is a spontaneous report from a non-contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 01Apr2021 at 13:45 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient experienced swollen lymph node near collar bone on the side she got vaccinated. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event swollen lymph node near collar bone was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, SARS-CoV-2 test
Clinical narrative: Severe throat and body ache; Severe throat and body ache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 02Apr2021(at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included loratadine (CLARITIN), ascorbic acid, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate (ONE-A-DAY) and ibuprofen (MANUFACTURER UNKNOWN) from an unknown date for unspecified indication. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, four days after the vaccination, the patient experienced severe throat ache and body ache and lasting longer than one week. On 09Apr2021, the patient underwent COVID-19 test (Nasal Swab) and the result was Negative. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported event. The clinical outcome of the events severe throat ache and body ache were not resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Mycobacterium tuberculosis complex test, Skin discolouration, Vaccination site inflammation, Vaccination site pruritus
Clinical narrative: Injection site became inflamed; still have the spot on my arm and it is still itchy at times but has reduced to more of a discoloration of skin.; Injection site became inflamed and itchy; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Mar2021 at 13:30 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder, tree nuts allergy and allergy to bell peppers and poppy seeds. Concomitant medications included sertraline hydrochloride (ZOLOFT) and lamotrigine (LAMICTAL) both from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, the patient had to get a tuberculosis (TB) test for work and the test came back as a false positive. The test was taken two weeks after the COVID vaccine. The patient never had a reaction to the tuberculosis (TB) test as severe. The injection site became inflamed and itchy. To rule out TB, the patient obtained a chest X-ray that proved that she did not have TB. The patient still had the spot on her arm and it was still itchy at times but has reduced to more of a discoloration of skin. Therapeutic measures were not taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events injection site became inflamed and itchy and discoloration of skin was recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Influenza, Migraine, Pain, Pyrexia
Clinical narrative: It felt the flu x2; After my first dose about 3 to Four hours after I got a severe migraine; diarrhea; fever; body ache; body was just craving anykind of juice I got very thirsty; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 13:45(at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included meningioma, stent in head, hypertension, rheumatoid, osteoporosis and disc degradation. The patient had unspecified allergies to medications, food, or other products. The patient received unspecified medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 at 16:45 the patient experienced, after three to four hours of first dose, severe migraine, diarrhea, fever, body aches and could not got out of bed. It felt the flu x2 and the body was just craving any kind of juice as felt very thirsty. Had seen some of these side effects on the website but did not see some of the ones that what the patient had experienced. And it was known that quite a few people that have had the same. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event severe migraine, diarrhea, fever, body aches, felt flu, could not get out of bed and thirsty were recovering at the time of this report.  No follow up attempts are needed; information about lot/batch number cannot be obtained.